SecBot SecBot
Institutional Cluster

SRPT

Sarepta Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed13d 13h ago
Institutional cluster: 3 buyers, 3 sellers (mixed)
Actionable Insight • Neutral

The cluster shows modest net selling by asset managers with no insider buying to offset it. Monitor upcoming Q3 earnings and any pipeline updates for Sarepta's Duchenne muscular dystrophy therapies, as the selling may reflect sector rotation or risk reduction ahead of results.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$18.54
T+0 close · Nov 3, 2026 · via day close
Latest settled
−11.43%
T+5 · $16.42
Vs SPY
−10.85%
α at T+5
Next horizon
T+20
in 15d
  1. T+0 · Nov 3 $18.54entry
  2. T+1 · 13d ago +2.43%α +0.78% · $18.99
  3. T+5 · 7d ago −11.43%α −10.85% · $16.42
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three asset managers added small positions in Sarepta Therapeutics during Q3 2026, while three others trimmed, led by Mackenzie Financial reducing its stake by $6.0M. The net institutional activity was negative ($5.2M net selling), and no insider buying corroborates the cluster. The mixed signals and 45-day reporting lag limit the near-term read-through.

Key Financial Metrics

Direction
distributing
Buy Value
$4.6M
Sell Value
$10.7M
Net Flow
-$5.2M

Institutional Positions

Net institutional flow: -$5.2M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Creative PlanningADD+71.8%$2.0M$832.0K
Alps AdvisorsADD+31.3%$2.5M$635.0K
Nisa Investment AdvisorsADD+40%$83.0K$25.0K

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
Mackenzie FinancialTRIM-56.2%$10.8M-$6.0M
Farther Finance AdvisorsTRIM-52.4%$42.0K-$22.0K
Wealth Enhancement Advisory ServicesTRIM-64.8%$1.0M-$689.0K

Key Facts

  • 3 buyers added $1.5M in net new holdings (total current value $4.6M)
  • 3 sellers reduced holdings by $6.7M (net selling of $5.2M across all 6 funds)
  • Mackenzie Financial was the largest seller, trimming 56.2% of its stake ($6.0M reduction)
  • No open-market insider buying detected in the same window (confluence score 19/100)
  • All six funds are asset managers; no activist or hedge fund involvement
  • 13F data is as of quarter-end 2026-Q3, filed with a 45-day lag

Financial Impact

Net institutional selling of $5.2M across 6 funds; largest single move was Mackenzie Financial's $6.0M reduction

institutional ownership

Risk Factors

  • 13F data is stale (45-day lag); positions may have changed since quarter-end
  • All funds are asset managers; no high-conviction activist or hedge fund involvement
  • Net selling of $5.2M is small relative to $2.0B market cap (0.26%)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-SRPT-2026-Q3

Track record

9 reports on SRPT

Performance horizon
Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $16.07 settles Dec 14
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $16.42 settles Dec 9
  3. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $17.82 settles Dec 7
  4. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Viewing Entry $18.54 settles Dec 2
  5. Jul 27, 202616w ago 8-K Neutral 3/10 Entry $15.89 to $18.13 ▲ +14.10% +10.80% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $15.00 to $20.52 ▲ +36.80% +34.91% vs SPY
  7. Jun 4, 202623w ago 8-K Neutral 3/10 Entry $15.75 to $19.18 ▲ +21.78% +19.92% vs SPY
  8. Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $20.89 to $16.67 ▼ −20.18% −25.14% vs SPY
  9. Feb 25, 202637w ago 8-K Mixed 7/10 Entry $17.45 to $21.68 ▲ +24.24% +30.65% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 9h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026